Log inSign up
Home/Library/Metabolic/Semaglutide

Semaglutide

Popular

GLP-1 receptor agonist

4.8286 reviews
Research use only Third-party tested
CategoryMetabolic
Half-life~1 week
FormatLyophilized
Storage2-8°C
Purity>99%

Research context

Extensive human evidence exists for approved products. Off-label or unapproved versions require additional caution.

  • Weight-loss and appetite-regulation claims within prescription programs.
  • Before/after photos in online communities.
  • Interest in cardiovascular and metabolic outcomes beyond cosmetic weight changes.

Evidence snapshot

See full evidence tab
Clinical Studies
62
Animal Studies
48
In Vitro Studies
31
Reviews / Meta-analyses
18

Last updated: June 2025

Quick facts

Aliases
Wegovy
Molecular weight
TBD
Sequence length
TBD
Product type
Synthetic
CAS / Registry
TBD
Appearance
White lyophilized powder
Solubility
Water

Safety notes

For research use only. Not for human or veterinary use.

  • Common research observations: nausea, reduced appetite, GI discomfort
  • Monitor hydration and nutrient intake in long-term studies
  • Consult current literature for full safety profile and contraindications

Popular research protocols

View all protocols
Weight management5-15 mg weekly
Type 2 diabetes7-20 mg weekly
Cardiometabolic risk9-25 mg weekly
Research use onlyAll peptides are intended for laboratory research purposes only. Not for human or veterinary use.